| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Jaguar Health Inc (NASDAQ: JAGX)
JAGX Technical Analysis
1.5
| As on 9th Jun 2023 JAGX STOCK Price closed @ 0.65 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.42 & Sell for SHORT-TERM with Stoploss of 0.79 we also expect STOCK to react on Following IMPORTANT LEVELS. |
JAGXSTOCK Price
| Open | 0.67 | Change | Price | % |
| High | 0.67 | 1 Day | -0.01 | -1.52 |
| Low | 0.61 | 1 Week | -0.01 | -1.52 |
| Close | 0.65 | 1 Month | 0.13 | 25.00 |
| Volume | 380100 | 1 Year | -0.73 | -52.90 |
| 52 Week High 6.38 | 52 Week Low 0.08 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| JAGX Daily Charts |
JAGX Intraday Charts |
Whats New @ Bazaartrend |
JAGX Free Analysis |
|
|
JAGX Important Levels Intraday
| RESISTANCE | 0.77 |
| RESISTANCE | 0.73 |
| RESISTANCE | 0.71 |
| RESISTANCE | 0.68 |
| SUPPORT | 0.62 |
| SUPPORT | 0.59 |
| SUPPORT | 0.57 |
| SUPPORT | 0.53 |
JAGX Forecast April 2024
| 4th UP Forecast | 1.57 |
| 3rd UP Forecast | 1.28 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 0.91 |
| 1st DOWN Forecast | 0.39 |
| 2nd DOWN Forecast | 0.21 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | -0.27 |
JAGX Weekly Forecast
| 4th UP Forecast | 0.96 |
| 3rd UP Forecast | 0.86 |
| 2nd UP Forecast | 0.80 |
| 1st UP Forecast | 0.74 |
| 1st DOWN Forecast | 0.56 |
| 2nd DOWN Forecast | 0.50 |
| 3rd DOWN Forecast | 0.44 |
| 4th DOWN Forecast | 0.34 |
JAGX Forecast2024
| 4th UP Forecast | 14.95 |
| 3rd UP Forecast | 10.36 |
| 2nd UP Forecast | 7.53 |
| 1st UP Forecast | 4.69 |
| 1st DOWN Forecast | -3.39 |
| 2nd DOWN Forecast | -6.23 |
| 3rd DOWN Forecast | -9.06 |
| 4th DOWN Forecast | -13.65 |
Jaguar Health Inc ( NASDAQ USA Symbol : JAGX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JAGX Business Profile
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. It markets Mytesi, a crofelemer 125 mg delayed-release tablet for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. It develops Mytesi for multiple possible follow-on indications, including diarrhea related to targeted cancer therapy; orphan-drug indications for infants and children with congenital diarrheal disorders and short bowel syndrome; supportive care for inflammatory bowel disease; irritable bowel syndrome; and for idiopathic/functional diarrhea, as well as a second-generation proprietary anti-secretory agent is in development for cholera. The company also develops Crofelemer, a drug product candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California. Address: 200 Pine Street, San Francisco, CA, United States, 94104
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service